Cargando…

Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response

Detalles Bibliográficos
Autores principales: Trøseid, Marius, Diallo, Alpha, Hites, Maya, Røttingen, John-Arne, Yazdanpanah, Yazdan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752190/
https://www.ncbi.nlm.nih.gov/pubmed/35031489
http://dx.doi.org/10.1016/j.cmi.2021.12.014
_version_ 1784631834786660352
author Trøseid, Marius
Diallo, Alpha
Hites, Maya
Røttingen, John-Arne
Yazdanpanah, Yazdan
author_facet Trøseid, Marius
Diallo, Alpha
Hites, Maya
Røttingen, John-Arne
Yazdanpanah, Yazdan
author_sort Trøseid, Marius
collection PubMed
description
format Online
Article
Text
id pubmed-8752190
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-87521902022-01-12 Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response Trøseid, Marius Diallo, Alpha Hites, Maya Røttingen, John-Arne Yazdanpanah, Yazdan Clin Microbiol Infect Letter to the Editor European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022-05 2022-01-12 /pmc/articles/PMC8752190/ /pubmed/35031489 http://dx.doi.org/10.1016/j.cmi.2021.12.014 Text en © 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Trøseid, Marius
Diallo, Alpha
Hites, Maya
Røttingen, John-Arne
Yazdanpanah, Yazdan
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response
title Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response
title_full Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response
title_fullStr Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response
title_full_unstemmed Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response
title_short Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response
title_sort accelerating clinical trial implementation in the context of the covid-19 pandemic: author's response
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752190/
https://www.ncbi.nlm.nih.gov/pubmed/35031489
http://dx.doi.org/10.1016/j.cmi.2021.12.014
work_keys_str_mv AT trøseidmarius acceleratingclinicaltrialimplementationinthecontextofthecovid19pandemicauthorsresponse
AT dialloalpha acceleratingclinicaltrialimplementationinthecontextofthecovid19pandemicauthorsresponse
AT hitesmaya acceleratingclinicaltrialimplementationinthecontextofthecovid19pandemicauthorsresponse
AT røttingenjohnarne acceleratingclinicaltrialimplementationinthecontextofthecovid19pandemicauthorsresponse
AT yazdanpanahyazdan acceleratingclinicaltrialimplementationinthecontextofthecovid19pandemicauthorsresponse